CannaPharmaRX, Inc.
CPMD
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 656.60K | 231.60K | 335.30K | 482.10K | 312.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 656.60K | 231.60K | 335.30K | 482.10K | 312.20K |
| Cost of Revenue | 1.10M | 852.80K | 837.90K | 2.19M | 668.30K |
| Gross Profit | -440.00K | -621.20K | -502.60K | -1.71M | -356.20K |
| SG&A Expenses | 495.60K | 164.20K | 165.10K | -156.30K | 159.80K |
| Depreciation & Amortization | -- | -- | -- | -87.30K | -- |
| Other Operating Expenses | -- | -- | -- | 51.00K | -- |
| Total Operating Expenses | 1.59M | 1.02M | 1.00M | 2.00M | 828.10K |
| Operating Income | -935.60K | -785.40K | -667.70K | -1.52M | -516.00K |
| Income Before Tax | -1.48M | -1.41M | -690.60K | -3.74M | 188.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.48M | -1.41M | -690.60K | -3.74M | 188.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.48M | -1.41M | -690.60K | -3.74M | 188.40K |
| EBIT | -935.60K | -785.40K | -667.70K | -1.52M | -516.00K |
| EBITDA | -- | -785.40K | -667.70K | -1.49M | -516.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 662.50M | 662.50M | 662.50M | 662.77M | 662.50M |
| Average Diluted Shares Outstanding | 662.50M | 662.50M | 662.50M | 662.77M | 662.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |